Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Adagene Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −3 vs. Q1 2024
- Shares held
- 11.2M
- −1.07M (−8.7%) vs. Q1 2024
- Total value
- $33.7M
- −$632.6K (−1.8%) vs. Q1 2024
- New holders
- 2
- 2 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADAG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $81.0M |
| Q1 2026 | 25 | $9.70M |
| Q4 2025 | 17 | $6.03M |
| Q3 2025 | 17 | $11.3M |
| Q2 2025 | 15 | $11.8M |
| Q1 2025 | 14 | $11.6M |
| Q4 2024 | 15 | $20.3M |
| Q3 2024 | 13 | $25.3M |
| Q2 2024 | 14 | $33.7M |
| Q1 2024 | 17 | $34.3M |
| Q4 2023 | 11 | $15.5M |
| Q3 2023 | 10 | $6.16M |
| Q2 2023 | 10 | $6.02M |
| Q1 2023 | 11 | $6.02M |
| Q4 2022 | 9 | $5.58M |
| Q3 2022 | 11 | $7.60M |
| Q2 2022 | 15 | $15.4M |
| Q1 2022 | 15 | $29.7M |
| Q4 2021 | 16 | $67.3M |
| Q3 2021 | 19 | $126.6M |
| Q2 2021 | 16 | $80.5M |
| Q1 2021 | 27 | $115.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Adagene Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| WuXi AppTec Co., Ltd. | 3,982,902 | $12.2M | 52.26% | 00.0% | Unchanged |
| FIL Ltd | 3,826,400 | $11.7M | 0.01% | −18,436−0.5% | Reduced |
| FMR LLC | 1,330,673 | $4.07M | 0.00% | −18,312−1.4% | Reduced |
| SC China Holding Ltd | 1,343,364 | $3.47M | 0.13% | 00.0% | Unchanged |
| General Atlantic LLC | 264,000 | $807.8K | 0.03% | 00.0% | Unchanged |
| Barclays PLC | 186,903 | $572.1K | 0.00% | +11,773+6.7% | Added |
| Exome Asset Management LLC | 150,876 | $461.8K | 0.41% | −4,507−2.9% | Reduced |
| Morgan Stanley | 93,894 | $287.4K | 0.00% | +8,217+9.6% | Added |
| Catalina Capital Group, LLC | 16,752 | $51.3K | 0.02% | +16,752 | New |
| Geode Capital Management, LLC | 10,309 | $31.5K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 8,965 | $27.4K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 8,300 | $25.0K | 0.00% | +8,300 | New |
| UBS Group AG | 164 | $502 | 0.00% | −250−60.4% | Reduced |
| Qube Research & Technologies Ltd | 47 | $144 | 0.00% | 00.0% | Unchanged |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,020,000−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −28,620−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −15,181−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,995−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −538−100.0% | Sold out |